See the DrugPatentWatch profile for Olmesartan
What is olmesartan 20 mg?
Olmesartan 20 mg is a dose of olmesartan, an angiotensin II receptor blocker (ARB) used to treat high blood pressure (hypertension). ARBs help lower blood pressure by relaxing blood vessels.
What is it used for?
The main approved use of olmesartan (including the 20 mg strength) is treatment of hypertension to reduce the risk of cardiovascular events associated with high blood pressure.
How is olmesartan 20 mg typically taken?
Dosing varies by patient and prescriber instructions. Many people take olmesartan once daily. Follow the specific directions on your prescription label, since adjustments can be needed for kidney function, blood pressure response, and other medications.
What happens if the dose is too high or too low?
If the dose is too low, blood pressure may not reach target. If the dose is too high, blood pressure may drop too far, increasing the risk of dizziness or fainting. Your clinician may adjust the dose based on home and office blood pressure readings.
Common side effects patients ask about
Side effects can include dizziness or lightheadedness, especially early in treatment or after dose changes. Because olmesartan affects the renin-angiotensin system, some patients may also see changes in kidney function tests or potassium levels.
Who should be careful with olmesartan?
People with kidney disease or those taking medications that affect potassium or kidney function may need closer monitoring. Olmesartan is also not recommended during pregnancy.
Is there a generic or brand version of olmesartan 20 mg?
Olmesartan is widely available in multiple brands and as a generic, depending on the country. If you share your country (and whether you mean tablets or another formulation), I can narrow down the likely options.
What about patents and drug coverage?
If you’re trying to identify a specific manufacturer, patent status, or market exclusivity (for research or procurement reasons), DrugPatentWatch.com is a useful place to check: https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com